EUVIMEDEUVIMED entdecken
Crossref

BIO 300: A Prophylactic Radiation Countermeasure for Acute Radiation Syndrome

Vijay K Singh iD, Artur A Serebrenik iD, Stephen Y Wise iD, Sarah A Petrus iD, Oluseyi O Fatanmi iD, Michael D Kaytor iD

Military Medicine · 19.08.2024 · 189 (Supplement_3) · 390-398

DOI: 10.1093/milmed/usae156 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Military Medicine, online erschienen am 19.08.2024. Verfasst von Vijay K Singh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Molecular Therapeutics, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bet…. Hauptthemen laut MEDLINE: Acute Radiation Syndrome, Macaca mulatta, Radiation-Protective Agents. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Joint Program Committee.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Exposure to high doses of ionizing radiation can result in hematopoietic acute radiation syndrome. Currently, there is no radiation medical countermeasure approved by the U.S. FDA which can be used before radiation exposure to protect exposed individuals. Here we aimed to evaluate the therapeutic potential of an aqueous suspension of synthetic genistein nanoparticles (BIO 300) as a radioprotectant in a pilot efficacy study using a nonhuman primate model of total body irradiation. Materials and Methods Eight rhesus macaques were divided into two groups; four received vehicle and four received BIO 300 Injectable Suspension 24 h before 5.8 Gy total-body irradiation. Survival, blood cell counts, blood chemistry, and clinical parameters were monitored over the 60 days of the study. Tissues were collected at necropsy 60 days post-irradiation or from animals that met unscheduled euthanasia criteria and subjected to histopathological analysis. Tissues analyzed included the duodenum, jejunum, ileum, sternum, lung, heart, liver, kidney, spleen, gut-associated lymphoid tissue, and urinary bladder.

Results

In this pilot study, all BIO 300 Injectable Suspension treated animals survived to day 60, while only 50% of the vehicle-treated animals survived. We found that BIO 300 Injectable Suspension did not mediate an improvement in blood cell counts (e.g., neutrophils, platelets, white blood cells). However, BIO 300 Injectable Suspension treated animals had a lower incidence of fever and febrile neutropenia, were able to better maintain their body weight post radiation exposure, and exhibited less anemia and faster recovery from anemia. Histopathological analysis revealed that BIO 300-treated animals had less irradiation-induced damage to the sternum and other tissues compared to vehicle controls.

Conclusions

BIO 300’s mechanism of action is complex and protection against irradiation is attainable without much improvement in the complete blood count (CBC) profile. BIO 300’s mechanism for radioprotection involves multiple biological pathways and systems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Radiation SyndromeMacaca mulattaRadiation-Protective AgentsAnimalsPilot ProjectsGenisteinMaleNanoparticlesWhole-Body IrradiationFemaleDisease Models, Animal

Substanzen

Radiation-Protective AgentsGenistein

Autor:innen und Institutionen

  • Department of Pharmacology and Molecular Therapeutics, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
  • Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
  • Humanetics Corporation, Minneapolis, MN 55435, USA.

ORCID-Profile: Vijay K Singh, Artur A Serebrenik, Stephen Y Wise, Sarah A Petrus, Oluseyi O Fatanmi, Michael D Kaytor

Förderung

  • Joint Program Committee

Zitieren

APA

Singh, V. K., Serebrenik, A. A., Wise, S. Y., Petrus, S. A., Fatanmi, O. O., & Kaytor, M. D. (2024). BIO 300: A Prophylactic Radiation Countermeasure for Acute Radiation Syndrome. Military Medicine, 189(Supplement_3), 390-398. https://doi.org/10.1093/milmed/usae156

Vancouver

Singh VK, Serebrenik AA, Wise SY, Petrus SA, Fatanmi OO, Kaytor MD. BIO 300: A Prophylactic Radiation Countermeasure for Acute Radiation Syndrome. Military Medicine. 2024;189(Supplement_3):390-398. doi:10.1093/milmed/usae156

BibTeX
@article{Singh2024,
  author = {Singh, Vijay K and Serebrenik, Artur A and Wise, Stephen Y and Petrus, Sarah A and Fatanmi, Oluseyi O and Kaytor, Michael D},
  title = {BIO 300: A Prophylactic Radiation Countermeasure for Acute Radiation Syndrome},
  journal = {Military Medicine},
  year = {2024},
  volume = {189},
  number = {Supplement_3},
  pages = {390--398},
  doi = {10.1093/milmed/usae156}
}
Kostenlos starten →